Takeda Pharmaceutical Steps Out
To register, please contact the Corporate Program at 212-715-1208 or email [email protected].
Takeda Pharmaceuticals, Japan’s largest drugmaker, recently appointed Christophe Weber as President and Chief Operating Officer. Drawing from his broad international experience, the 20-year veteran of the pharmaceutical industry is leading the company’s globalization while ensuring it stays faithful to the values laid down by the founding family over 230 years ago. In this speech, followed by a question and answer session, Mr. Weber will share his vision for Global One Takeda: an agile, diverse, “best-in-class” pharmaceutical company with a Japanese heritage and an expanding global footprint.
Christophe Weber, President & Chief Operating Officer, Takeda Pharmaceutical Company Limited
Karen Bechtel, Managing Director & Head of the Global healthcare Group, The Carlyle Group
6-6:30 pm Registration
6:30-7:30 Lecture and Q&A
Japan Society Corporate Members: Free, up to designated number of tickets; additional tickets $10
Japan Society Individual Members at Patron Circle level and above: $10
Academic and government: $10
Seating is available on a first come, first served basis.
Prepayment must be made with a credit card. All registrations and cancellations must be made at least 48 hours prior to the event. Substitutions are welcome.
For further information or assistance, please contact the Corporate Program at 212-715-1208 or email [email protected].
- Wednesday, November 5, 2014
- 6:00 pm